Header cover image

Polish (WIG) Pharma Industry Analysis

UpdatedJun 19, 2024
DataAggregated Company Financials
Companies5
  • 7D2.3%
  • 3M-2.2%
  • 1Y-8.8%
  • YTD-5.7%

Last week, the Pharma industry hasn't moved much but Biogened is up 10% in that time. As for the longer term, the industry has declined 13% in the last year. Looking forward, earnings are forecast to grow by 102% annually.

Industry Valuation and Performance

Has the Polish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 19 Jun 2024zł1.1bzł310.8m-zł61,217,640.0012.1x-18.7x3.7x
Fri, 17 May 2024zł1.2bzł311.0m-zł43,187,309.0013.1x-27.7x3.8x
Sun, 14 Apr 2024zł1.1bzł311.5m-zł40,173,065.0015.9x-28.4x3.7x
Tue, 12 Mar 2024zł1.2bzł311.5m-zł40,173,065.0015.2x-29.9x3.9x
Thu, 08 Feb 2024zł1.2bzł308.7m-zł39,880,934.0016.2x-29.9x3.9x
Sat, 06 Jan 2024zł1.2bzł308.7m-zł39,880,934.0011.7x-30.1x3.9x
Mon, 04 Dec 2023zł1.1bzł308.7m-zł39,880,934.0011.2x-28.5x3.7x
Wed, 01 Nov 2023zł1.1bzł302.0m-zł42,933,291.0011.2x-25.7x3.7x
Fri, 29 Sep 2023zł1.1bzł302.2m-zł42,609,118.0010.5x-26.2x3.7x
Sun, 27 Aug 2023zł1.3bzł287.0m-zł53,882,152.0011.4x-23.6x4.4x
Tue, 25 Jul 2023zł1.2bzł278.4m-zł53,806,540.0035.9x-22.3x4.3x
Thu, 22 Jun 2023zł1.2bzł278.4m-zł53,387,087.0034.7x-22.1x4.2x
Sat, 20 May 2023zł1.1bzł275.3m-zł51,408,128.009x-21.1x3.9x
Mon, 17 Apr 2023zł1.1bzł273.2m-zł44,427,333.008.9x-24.6x4x
Wed, 15 Mar 2023zł1.1bzł273.2m-zł44,427,333.008.2x-25.9x4.2x
Fri, 10 Feb 2023zł1.1bzł270.3m-zł44,201,704.007.7x-25.9x4.2x
Sun, 08 Jan 2023zł1.0bzł270.3m-zł44,201,704.008x-23.1x3.8x
Tue, 06 Dec 2022zł989.3mzł270.3m-zł44,201,704.008.2x-22.4x3.7x
Thu, 03 Nov 2022zł942.2mzł260.7m-zł40,809,798.008.4x-23.1x3.6x
Sat, 01 Oct 2022zł898.6mzł261.1m-zł40,391,998.009.1x-22.2x3.4x
Mon, 29 Aug 2022zł1.1bzł265.7m-zł29,303,736.009.1x-37.3x4.1x
Wed, 27 Jul 2022zł1.2bzł264.2m-zł29,985,890.0010.9x-38.7x4.4x
Fri, 24 Jun 2022zł1.2bzł264.2m-zł29,985,890.0010x-38.8x4.4x
Sun, 22 May 2022zł1.3bzł269.1m-zł24,188,890.0010.5x-55.4x5x
Tue, 19 Apr 2022zł1.8bzł235.3m-zł1,158,483.0063.8x-1510.9x7.4x
Thu, 17 Mar 2022zł1.8bzł358.1mzł72.0m12.7x25.4x5.1x
Sat, 12 Feb 2022zł2.0bzł350.0mzł71.4m18x28.1x5.7x
Mon, 10 Jan 2022zł2.3bzł350.0mzł71.4m14.6x31.6x6.4x
Wed, 08 Dec 2021zł2.1bzł350.0mzł71.4m13.8x29.8x6.1x
Fri, 05 Nov 2021zł2.5bzł344.7mzł81.6m10.8x30.6x7.2x
Sun, 03 Oct 2021zł2.3bzł330.2mzł84.1m11.4x27.4x7x
Tue, 31 Aug 2021zł2.6bzł330.5mzł86.5m11.4x30.3x7.9x
Wed, 07 Jul 2021zł2.7bzł330.5mzł86.5m16x31.1x8.1x
Price to Earnings Ratio

31.1x


Total Market Cap: zł2.7bTotal Earnings: zł86.5mTotal Revenue: zł330.5mTotal Market Cap vs Earnings and Revenue0%0%0%
Polish Pharma Industry Price to Earnings3Y Average -50.7x202220232024
Current Industry PE
  • Investors are pessimistic on the Polish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 4.8x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 2.0% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the Polish Healthcare industry?

PL Market1.51%
Healthcare0.14%
Pharma2.29%
Pharma2.29%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CLN Celon Pharmazł15.963.5%
+zł27.6m
1.0%PS3.9x
BGD Biogenedzł21.8010.1%
+zł4.9m
55.7%PE12.1x
CBD Cannabis Polandzł0.690.1%
+zł49.2k
130.1%PS486.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CLN

zł15.96

Celon Pharma

7D

3.5%

1Y

1.0%

MOC

zł13.82

Molecure

7D

-2.7%

1Y

-40.2%

BGD

zł21.80

Biogened

7D

10.1%

1Y

55.7%

CBD

zł0.69

Cannabis Poland

7D

0.1%

1Y

130.1%

LCN

zł0.39

Labocanna

7D

-6.1%

1Y

-9.8%